UNSPSC 51143218: Nicotine polacrilex

This classification denotes a nicotinic agonist and alkaloid with the molecular formula C10H14N2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 6M3C89ZY6R, chemically known as xl all insecti-cide, emo-nib but more generally known as nicotine, which bears US NIH Compound Identifier 942. European Medicines Agency schedules Nicotine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB14645MIG. World Health Organization schedules nicotine in its Anatomical Therapeutic Chemical (ATC) Classification.

Most nations, for tariff and trade purposes, schedule nicotine polacrilex under HS 29399990 and SITC 54149. SMILES: CN1CCC[C@H]1C2CCCNC2.

UNSPSC 51143218 Nicotine polacrilex is a Commodity code representing pharmaceutical nicotine replacement products typically used in smoking cessation and harm-reduction programs. However, the recent state and local activity tagged to this code shows a significant mismatch: the single identified opportunity involves procurement of naloxone and drug deactivation systems for opioid harm reduction, not nicotine replacement therapy. This disconnect suggests either a data-tagging error in the source or minimal legitimate solicitation activity under the nicotine polacrilex code proper.

The one recent opportunity on file is Seminole County, Florida's IFB 60459723LAS, posted June 30, 2026, with a response deadline of July 26, 2023, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually through quarterly deliveries to the Seminole County Community Health Building in Sanford. The procurement requires electronic bid submission via the county's e-Procurement Portal, unit pricing for each line item, drug-free workplace and E-Verify certification, and full inclusion of shipping and delivery costs. The contract carries a two-year initial term with a one-year renewal option, a three-month probationary termination clause, and potential FEMA funding with associated federal compliance requirements. This is the sole recent state or local opportunity identified under the code, and it does not reflect the nominal scope of nicotine polacrilex procurement; absent additional tagged opportunities in other jurisdictions, business development professionals should treat this code as showing little active state and local solicitation relevant to actual nicotine replacement products.